Preoperative [18F]FDG PET/CT maximum standardized uptake value predicts recurrence of uterine cervical cancer

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 37, Issue 8, 2010, Pages 1467-1473

  Chung, Hyun Hoon ^a   Nam, Byung Ho ^b   Kim, Jae Weon ^a   Kang, Keon Wook ^c   Park, Noh Hyun ^a   Song, Yong Sang ^a   Chung, June Key ^c   Kang, Soon Beom ^a  

^a Seoul National University College of Medicine   (South Korea)

^b National Cancer Center   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

Cervical cancer; FDG PET CT; Recurrence; SUV

Indexed keywords

BARIUM SULFATE; FLUORODEOXYGLUCOSE F 18; DIAGNOSTIC AGENT;

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FOLLOW UP; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PELVIS LYMPH NODE; POSITRON EMISSION TOMOGRAPHY; PROGNOSIS; TUMOR VOLUME; UTERINE CERVIX CANCER; FEMALE; METABOLISM; MIDDLE AGED; PREOPERATIVE PERIOD; RECURRENT DISEASE; RETROSPECTIVE STUDY; TRANSPORT AT THE CELLULAR LEVEL; UTERINE CERVIX TUMOR;

ADULT; AGED; AGED, 80 AND OVER; BIOLOGICAL TRANSPORT; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MIDDLE AGED; POSITRON-EMISSION TOMOGRAPHY; PREOPERATIVE PERIOD; PROGNOSIS; RECURRENCE; RETROSPECTIVE STUDIES; TOMOGRAPHY, X-RAY COMPUTED; UTERINE CERVICAL NEOPLASMS; YOUNG ADULT;

EID: 77956186153     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-010-1413-5     Document Type: Article

References (31)

1. LH Ellenson TC Wu 2004 Focus on endometrial and cervical cancer Cancer Cell 5 533 538 10.1016/j.ccr.2004.05.029 1:CAS:528:DC%2BD2cXltlGgs7Y%3D 15193256
2. YT Kim 2009 Current status of cervical cancer and HPV infection in Korea J Gynecol Oncol 20 1 7 10.3802/jgo.2009.20.1.1 19471667
3. JL Benedet F Odicino P Maisonneuve U Beller WT Creasman AP Heintz, et al. 2001 Carcinoma of the cervix uteri J Epidemiol Biostat 6 7 43 1:STN:280:DC%2BD3Mzht1Gnsg%3D%3D 11385777
4. F Landoni A Maneo A Colombo F Placa R Milani P Perego, et al. 1997 Randomised study of radical surgery versus radiotherapy for stage Ib-IIa cervical cancer Lancet 350 535 540 10.1016/S0140-6736(97)02250-2 1:STN:280:DyaK2svjtVKltQ%3D%3D 9284774
5. CK Chung WA Nahhas JA Stryker SL Curry AB Abt R Mortel 1980 Analysis of factors contributing to treatment failures in stages IB and IIA carcinoma of the cervix Am J Obstet Gynecol 138 550 556 1:STN:280:DyaL3M%2Fjs12lsg%3D%3D 7425018
6. JR van Nagell Jr ES Donaldson EG Wood JC Parker Jr 1978 The significance of vascular invasion and lymphocytic infiltration in invasive cervical cancer Cancer 41 228 234 10.1002/1097-0142(197801)41:1<228::AID-CNCR2820410131>3. 0.CO;2-6 626931
7. G Delgado B Bundy R Zaino BU Sevin WT Creasman F Major 1990 Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study Gynecol Oncol 38 352 357 10.1016/0090-8258(90)90072-S 1:STN:280: DyaK3M%2FjtlWquw%3D%3D 2227547
8. J Boyce RG Fruchter AD Nicastri PC Ambiavagar MS Reinis JH Nelson Jr 1981 Prognostic factors in stage I carcinoma of the cervix Gynecol Oncol 12 154 165 10.1016/0090-8258(81)90145-1 1:STN:280:DyaL38%2FltFCrsw%3D%3D 7297927
9. SE Waggoner 2003 Cervical cancer Lancet 361 2217 2225 10.1016/S0140-6736(03)13778-6 12842378
10. M Werner-Wasik CH Schmid L Bornstein HG Ball DM Smith H Madoc-Jones 1995 Prognostic factors for local and distant recurrence in stage I and II cervical carcinoma Int J Radiat Oncol Biol Phys 32 1309 1317 1:STN:280: DyaK2Mzmt1GqsQ%3D%3D 7635770
11. LC Horn U Fischer G Raptis K Bilek B Hentschel 2007 Tumor size is of prognostic value in surgically treated FIGO stage II cervical cancer Gynecol Oncol 107 310 315 10.1016/j.ygyno.2007.06.026 17826822
12. PG Rose LP Adler M Rodriguez PF Faulhaber FW Abdul-Karim F Miraldi 1999 Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: a surgicopathologic study J Clin Oncol 17 41 45 1:STN:280:DyaK1MzosFequg%3D%3D 10458216
13. PW Grigsby BA Siegel F Dehdashti 2001 Lymph node staging by positron emission tomography in patients with carcinoma of the cervix J Clin Oncol 19 3745 3749 1:STN:280:DC%2BD3MvptVCksw%3D%3D 11533097
14. PW Grigsby BA Siegel F Dehdashti J Rader I Zoberi 2004 Posttherapy [18F] fluorodeoxyglucose positron emission tomography in carcinoma of the cervix: response and outcome J Clin Oncol 22 2167 2171 10.1200/JCO.2004.09.035 15169804
15. HH Chung SK Kim TH Kim S Lee KW Kang JY Kim, et al. 2006 Clinical impact of FDG-PET imaging in post-therapy surveillance of uterine cervical cancer: from diagnosis to prognosis Gynecol Oncol 103 165 170 10.1016/j.ygyno.2006.02.016 16574205
16. HH Chung H Jo WJ Kang JW Kim NH Park YS Song, et al. 2007 Clinical impact of integrated PET/CT on the management of suspected cervical cancer recurrence Gynecol Oncol 104 529 534 10.1016/j.ygyno.2006.09.009 17049971
17. JF Vansteenkiste SG Stroobants PJ Dupont PR De Leyn EK Verbeken GJ Deneffe, et al. 1999 Prognostic importance of the standardized uptake value on (18)F-fluoro-2-deoxy-glucose-positron emission tomography scan in non-small-cell lung cancer: an analysis of 125 cases. Leuven Lung Cancer Group J Clin Oncol 17 3201 3206 1:STN:280:DyaK1MvjvVWruw%3D%3D 10506619
18. AS Allal P Dulguerov M Allaoua CA Haenggeli A El-Ghaziel W Lehmann, et al. 2002 Standardized uptake value of 2-[(18)F] fluoro-2-deoxy-D-glucose in predicting outcome in head and neck carcinomas treated by radiotherapy with or without chemotherapy J Clin Oncol 20 1398 1404 10.1200/JCO.20.5.1398 1:CAS:528:DC%2BD38XisVWmu7Y%3D 11870185
19. RJ Downey T Akhurst M Gonen A Vincent MS Bains S Larson, et al. 2004 Preoperative F-18 fluorodeoxyglucose-positron emission tomography maximal standardized uptake value predicts survival after lung cancer resection J Clin Oncol 22 3255 3260 10.1200/JCO.2004.11.109 15310769
20. R Sasaki R Komaki H Macapinlac J Erasmus P Allen K Forster, et al. 2005 [18F]fluorodeoxyglucose uptake by positron emission tomography predicts outcome of non-small-cell lung cancer J Clin Oncol 23 1136 1143 10.1200/JCO.2005.06.129 1:CAS:528:DC%2BD2MXitl2gtbc%3D 15718309
21. AS Allal DO Slosman T Kebdani M Allaoua W Lehmann P Dulguerov 2004 Prediction of outcome in head-and-neck cancer patients using the standardized uptake value of 2-[18F]fluoro-2-deoxy-D-glucose Int J Radiat Oncol Biol Phys 59 1295 1300 1:CAS:528:DC%2BD2cXmtVWhsLk%3D 15275712
22. K Higashi K Ito Y Hiramatsu T Ishikawa T Sakuma I Matsunari, et al. 2005 18F-FDG uptake by primary tumor as a predictor of intratumoral lymphatic vessel invasion and lymph node involvement in non-small cell lung cancer: analysis of a multicenter study J Nucl Med 46 267 273 15695786
23. JK Hoang LF Hoagland RE Coleman AD Coan JE Herndon 2nd EF Patz Jr 2008 Prognostic value of fluorine-18 fluorodeoxyglucose positron emission tomography imaging in patients with advanced-stage non-small-cell lung carcinoma J Clin Oncol 26 1459 1464 10.1200/JCO.2007.14.3628 18349396
24. TC Yen CY Lin HM Wang SF Huang CT Liao CJ Kang, et al. 2006 18F-FDG-PET for evaluation of the response to concurrent chemoradiation therapy with intensity-modulated radiation technique for stage T4 nasopharyngeal carcinoma Int J Radiat Oncol Biol Phys 65 1307 1314 1:CAS:528:DC%2BD28Xntl2ju7s%3D 16863922
25. MH Schwarzbach U Hinz A Dimitrakopoulou-Strauss F Willeke S Cardona G Mechtersheimer, et al. 2005 Prognostic significance of preoperative [18-F] fluorodeoxyglucose (FDG) positron emission tomography (PET) imaging in patients with resectable soft tissue sarcomas Ann Surg 241 286 294 10.1097/01.sla. 0000152663.61348.6f 15650639
26. F Xue LL Lin F Dehdashti TR Miller BA Siegel PW Grigsby 2006 F-18 fluorodeoxyglucose uptake in primary cervical cancer as an indicator of prognosis after radiation therapy Gynecol Oncol 101 147 151 10.1016/j.ygyno. 2005.10.005 1:CAS:528:DC%2BD28XhslyjsL8%3D 16263155
27. JK Schwarz BA Siegel F Dehdashti PW Grigsby 2007 Association of posttherapy positron emission tomography with tumor response and survival in cervical carcinoma JAMA 298 2289 2295 10.1001/jama.298.19.2289 1:CAS:528:DC%2BD2sXhtlGntL%2FE 18029833
28. EA Kidd BA Siegel F Dehdashti PW Grigsby 2007 The standardized uptake value for F-18 fluorodeoxyglucose is a sensitive predictive biomarker for cervical cancer treatment response and survival Cancer 110 1738 1744 10.1002/cncr.22974 17786947
29. YY Lee CH Choi CJ Kim H Kang TJ Kim JW Lee, et al. 2009 The prognostic significance of the SUVmax (maximum standardized uptake value for F-18 fluorodeoxyglucose) of the cervical tumor in PET imaging for early cervical cancer: preliminary results Gynecol Oncol 115 65 68 10.1016/j.ygyno.2009.06.022 19604567
30. TC Yen LC See CH Lai CW Yah-Huei KK Ng SY Ma, et al. 2004 18F-FDG uptake in squamous cell carcinoma of the cervix is correlated with glucose transporter 1 expression J Nucl Med 45 22 29 1:CAS:528:DC%2BD2cXht1artLc%3D 14734665
31. AL Harris 2002 Hypoxia - a key regulatory factor in tumour growth Nat Rev Cancer 2 38 47 10.1038/nrc704 1:CAS:528:DC%2BD38XhvF2jtL4%3D 11902584